Moderna Inc (MRNA)

12:58 PM

More Downside For Moderna Before The Breakthrough (NASDAQ:MRNA) - Seeking Alpha

12:58 PM

12:03 PM

Moderna Can't Buy Time To Defend COVID Vax UPC Claim - Law360

12:03 PM

04:30 AM

Guggenheim Capital LLC Reduces Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

04:30 AM

02:45 AM

Moderna's (MRNA) "Market Perform" Rating Reaffirmed at William Blair - MarketBeat

02:45 AM

12:47 PM

Altshuler Shaham Ltd Boosts Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

12:47 PM

Apr 21, 2025

What to Expect From Moderna's Q1 2025 Earnings Report - Nasdaq

Apr 21, 2025

Apr 21, 2025

Scotia Capital Inc. Has $284,000 Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 21, 2025

Apr 21, 2025

Brokerages Set Moderna, Inc. (NASDAQ:MRNA) Target Price at $58.70 - MarketBeat

Apr 21, 2025

Apr 21, 2025

Bridgewater Associates LP Makes New Investment in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 21, 2025

Apr 21, 2025

Wolfe Research Adjusts Moderna Price Target to $20 From $25, Keeps Underperform Rating - marketscreener.com

Apr 21, 2025

Apr 21, 2025

What To Expect From Moderna's Q1 2025 Earnings Report - Barchart.com

Apr 21, 2025

Apr 21, 2025

Preventive Vaccines Market Forecast 2025-2032- Growth - openPR.com

Apr 21, 2025

Apr 20, 2025

Where Will Moderna Be in 5 Years? - Nasdaq

Apr 20, 2025

Apr 20, 2025

Advisory Services Network LLC Purchases 16,555 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 20, 2025

Apr 20, 2025

Q1 Earnings Forecast for Moderna Issued By Leerink Partnrs - MarketBeat

Apr 20, 2025

Apr 19, 2025

Lobbying Update: $60,000 of MODERNA INC. lobbying was just disclosed - Nasdaq

Apr 19, 2025

Apr 18, 2025

Russell Investments Group Ltd. Increases Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 18, 2025

Apr 18, 2025

Bank of Montreal Can Trims Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 18, 2025

Apr 18, 2025

The Gutierrez Co. Sued Over Mold, Water Damage at Moderna Site — Boston Business Journal - Boston Real Estate Times

Apr 18, 2025

Apr 18, 2025

Moderna sues construction firm claiming leaks, mold at new drug plant - NBC Boston

Apr 18, 2025

Apr 18, 2025

Water leaks, mold plague Moderna's new manufacturing site, lawsuit claims - The Business Journals

Apr 18, 2025

Apr 17, 2025

Quinn Opportunity Partners LLC Purchases Shares of 16,500 Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 17, 2025

Apr 17, 2025

Moderna (MRNA) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance

Apr 17, 2025

Apr 17, 2025

US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years - Benzinga

Apr 17, 2025

Apr 17, 2025

Invesco Ltd. Acquires 979,858 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 17, 2025

Apr 17, 2025

Moderna Says New Drug Plant Riddled With Defects, Mold - Law360

Apr 17, 2025

Apr 17, 2025

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Legal & General Group Plc - MarketBeat

Apr 17, 2025

Apr 17, 2025

Moderna (MRNA) Leads Healthcare Short Interest in March - GuruFocus

Apr 17, 2025

Apr 17, 2025

Lansdowne Partners UK LLP Acquires New Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 17, 2025

Apr 16, 2025

Neuberger Berman Group LLC Reduces Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 16, 2025

Apr 16, 2025

Bloom Energy, Rogers, 3D Systems, Moderna, and EchoStar Stocks Trade Down, What You Need To Know - The Globe and Mail

Apr 16, 2025

Apr 16, 2025

Moderna permitted to start commercial mRNA vaccine manufacture in UK - The Pharma Letter

Apr 16, 2025

Apr 16, 2025

Leerink Partners Adjusts Moderna Price Target to $23 From $27, Maintains Underperform Rating - marketscreener.com

Apr 16, 2025

Apr 16, 2025

Moderna Co-Founder and MIT Legend Strengthens Decoy Therapeutics Drug Development Team - Stock Titan

Apr 16, 2025

Apr 16, 2025

MRNA Based Vaccines and Therapeutics Therapeutics Market Size - openPR.com

Apr 16, 2025

Apr 16, 2025

Renaissance Technologies LLC Grows Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 16, 2025

Apr 15, 2025

APG Asset Management N.V. Buys 203,792 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 15, 2025

Apr 15, 2025

FDA Special Assistant Høeg’s Vaccine Concerns On Display At ACIP - insights.citeline.com

Apr 15, 2025

Apr 15, 2025

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Shelton Capital Management - MarketBeat

Apr 15, 2025

Apr 15, 2025

Stocks Edge Up On Strong Bank Earnings, Netflix Soars, Dollar Rebounds: What's Driving Markets Tuesday? - Benzinga

Apr 15, 2025

Apr 15, 2025

Goldman Sachs Adjusts Moderna's Price Target to $35 From $49, Keeps Neutral Rating - MarketScreener

Apr 15, 2025

Apr 14, 2025

Redburn Atlantic Adjusts Moderna's Price Target to $52 From $55, Keeps Neutral Rating - MarketScreener

Apr 14, 2025

Apr 14, 2025

Morgan Stanley Issues Pessimistic Forecast for Moderna (NASDAQ:MRNA) Stock Price - MarketBeat

Apr 14, 2025

Apr 13, 2025

Aviva PLC Lowers Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Apr 13, 2025